Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
27
MBAI.CX Quote, Financials, Valuation and Earnings
Last price:
$0.08
Seasonality move
:
32.62%
Day range:
$0.08 - $0.08
52-week range:
$0.02 - $0.13
Dividend yield:
0%
P/E ratio:
7.62x
P/S ratio:
5.78x
P/B ratio:
3.47x
Volume:
--
Avg. volume:
60.7K
1-year change:
300%
Market cap:
$9M
Revenue:
$1.2M
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments, Inc.
|
-- | -- | -- | -- | -- |
|
FNQ.CX
Fineqia International, Inc.
|
-- | -- | -- | -- | -- |
|
GPK.CX
Grand Peak Capital Corp.
|
-- | -- | -- | -- | -- |
|
IDK.CX
ThreeD Capital, Inc.
|
-- | -- | -- | -- | -- |
|
QCA.CX
Quinsam Capital Corp.
|
-- | -- | -- | -- | -- |
|
ROBO.CX
Humanoid Global Holdings Corp.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments, Inc.
|
$0.08 | -- | $9M | 7.62x | $0.00 | 0% | 5.78x |
|
FNQ.CX
Fineqia International, Inc.
|
$0.0050 | -- | $8.3M | -- | $0.00 | 0% | 8.01x |
|
GPK.CX
Grand Peak Capital Corp.
|
$0.0800 | -- | $12.7M | -- | $0.00 | 0% | 84.57x |
|
IDK.CX
ThreeD Capital, Inc.
|
$0.06 | -- | $5.2M | 3.44x | $0.00 | 0% | 1.44x |
|
QCA.CX
Quinsam Capital Corp.
|
$0.05 | -- | $4.7M | -- | $0.00 | 0% | -- |
|
ROBO.CX
Humanoid Global Holdings Corp.
|
$0.67 | -- | $25.6M | -- | $0.00 | 0% | 432.34x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments, Inc.
|
-- | 8.489 | -- | 0.21x |
|
FNQ.CX
Fineqia International, Inc.
|
-153.33% | 4.896 | 27.17% | 0.00x |
|
GPK.CX
Grand Peak Capital Corp.
|
-- | -6.500 | -- | 13.82x |
|
IDK.CX
ThreeD Capital, Inc.
|
1.16% | 1.415 | 4.47% | 0.11x |
|
QCA.CX
Quinsam Capital Corp.
|
-- | 2.307 | -- | 4.89x |
|
ROBO.CX
Humanoid Global Holdings Corp.
|
13.75% | 24.971 | 1.05% | 2.06x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MBAI.CX
MedBright AI Investments, Inc.
|
-- | $347.9K | 40.48% | 40.84% | 305.18% | -$120.5K |
|
FNQ.CX
Fineqia International, Inc.
|
$144.9K | $116.7K | -11905.51% | -- | 78.8% | -$462.9K |
|
GPK.CX
Grand Peak Capital Corp.
|
-- | $23.6K | -5.54% | -5.54% | 75.16% | -$38.6K |
|
IDK.CX
ThreeD Capital, Inc.
|
$407.3K | -$2.8M | -54.27% | -54.82% | -625.68% | -$1.1M |
|
QCA.CX
Quinsam Capital Corp.
|
-- | $132.1K | -41.93% | -41.93% | -3.32% | -$116.6K |
|
ROBO.CX
Humanoid Global Holdings Corp.
|
$16.1K | -$2.5M | -406% | -548.95% | -15428.57% | -$1.1M |
MedBright AI Investments, Inc. vs. Competitors
-
Which has Higher Returns MBAI.CX or FNQ.CX?
Fineqia International, Inc. has a net margin of -179.59% compared to MedBright AI Investments, Inc.'s net margin of -340.38%. MedBright AI Investments, Inc.'s return on equity of 40.84% beat Fineqia International, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments, Inc.-- $0.00 $2.6M FNQ.CXFineqia International, Inc.97.84% -$0.00 -$1.5M -
What do Analysts Say About MBAI.CX or FNQ.CX?
MedBright AI Investments, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Fineqia International, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments, Inc. has higher upside potential than Fineqia International, Inc., analysts believe MedBright AI Investments, Inc. is more attractive than Fineqia International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments, Inc.0 0 0 FNQ.CXFineqia International, Inc.0 0 0 -
Is MBAI.CX or FNQ.CX More Risky?
MedBright AI Investments, Inc. has a beta of 1.312, which suggesting that the stock is 31.221% more volatile than S&P 500. In comparison Fineqia International, Inc. has a beta of 1.809, suggesting its more volatile than the S&P 500 by 80.905%.
-
Which is a Better Dividend Stock MBAI.CX or FNQ.CX?
MedBright AI Investments, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fineqia International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments, Inc. pays -- of its earnings as a dividend. Fineqia International, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or FNQ.CX?
MedBright AI Investments, Inc. quarterly revenues are $114K, which are smaller than Fineqia International, Inc. quarterly revenues of $148.1K. MedBright AI Investments, Inc.'s net income of $347.4K is higher than Fineqia International, Inc.'s net income of -$504.1K. Notably, MedBright AI Investments, Inc.'s price-to-earnings ratio is 7.62x while Fineqia International, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments, Inc. is 5.78x versus 8.01x for Fineqia International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments, Inc.5.78x 7.62x $114K $347.4K FNQ.CXFineqia International, Inc.8.01x -- $148.1K -$504.1K
-
Which has Higher Returns MBAI.CX or GPK.CX?
Grand Peak Capital Corp. has a net margin of -179.59% compared to MedBright AI Investments, Inc.'s net margin of 69.75%. MedBright AI Investments, Inc.'s return on equity of 40.84% beat Grand Peak Capital Corp.'s return on equity of -5.54%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments, Inc.-- $0.00 $2.6M GPK.CXGrand Peak Capital Corp.-- -- $3M -
What do Analysts Say About MBAI.CX or GPK.CX?
MedBright AI Investments, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Grand Peak Capital Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments, Inc. has higher upside potential than Grand Peak Capital Corp., analysts believe MedBright AI Investments, Inc. is more attractive than Grand Peak Capital Corp..
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments, Inc.0 0 0 GPK.CXGrand Peak Capital Corp.0 0 0 -
Is MBAI.CX or GPK.CX More Risky?
MedBright AI Investments, Inc. has a beta of 1.312, which suggesting that the stock is 31.221% more volatile than S&P 500. In comparison Grand Peak Capital Corp. has a beta of 6.699, suggesting its more volatile than the S&P 500 by 569.873%.
-
Which is a Better Dividend Stock MBAI.CX or GPK.CX?
MedBright AI Investments, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Grand Peak Capital Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments, Inc. pays -- of its earnings as a dividend. Grand Peak Capital Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or GPK.CX?
MedBright AI Investments, Inc. quarterly revenues are $114K, which are larger than Grand Peak Capital Corp. quarterly revenues of $31.4K. MedBright AI Investments, Inc.'s net income of $347.4K is higher than Grand Peak Capital Corp.'s net income of $21.9K. Notably, MedBright AI Investments, Inc.'s price-to-earnings ratio is 7.62x while Grand Peak Capital Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments, Inc. is 5.78x versus 84.57x for Grand Peak Capital Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments, Inc.5.78x 7.62x $114K $347.4K GPK.CXGrand Peak Capital Corp.84.57x -- $31.4K $21.9K
-
Which has Higher Returns MBAI.CX or IDK.CX?
ThreeD Capital, Inc. has a net margin of -179.59% compared to MedBright AI Investments, Inc.'s net margin of -632.46%. MedBright AI Investments, Inc.'s return on equity of 40.84% beat ThreeD Capital, Inc.'s return on equity of -54.82%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments, Inc.-- $0.00 $2.6M IDK.CXThreeD Capital, Inc.91.12% -$0.03 $29.1M -
What do Analysts Say About MBAI.CX or IDK.CX?
MedBright AI Investments, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand ThreeD Capital, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments, Inc. has higher upside potential than ThreeD Capital, Inc., analysts believe MedBright AI Investments, Inc. is more attractive than ThreeD Capital, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments, Inc.0 0 0 IDK.CXThreeD Capital, Inc.0 0 0 -
Is MBAI.CX or IDK.CX More Risky?
MedBright AI Investments, Inc. has a beta of 1.312, which suggesting that the stock is 31.221% more volatile than S&P 500. In comparison ThreeD Capital, Inc. has a beta of 0.015, suggesting its less volatile than the S&P 500 by 98.466%.
-
Which is a Better Dividend Stock MBAI.CX or IDK.CX?
MedBright AI Investments, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ThreeD Capital, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments, Inc. pays -- of its earnings as a dividend. ThreeD Capital, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or IDK.CX?
MedBright AI Investments, Inc. quarterly revenues are $114K, which are smaller than ThreeD Capital, Inc. quarterly revenues of $447K. MedBright AI Investments, Inc.'s net income of $347.4K is higher than ThreeD Capital, Inc.'s net income of -$2.8M. Notably, MedBright AI Investments, Inc.'s price-to-earnings ratio is 7.62x while ThreeD Capital, Inc.'s PE ratio is 3.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments, Inc. is 5.78x versus 1.44x for ThreeD Capital, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments, Inc.5.78x 7.62x $114K $347.4K IDK.CXThreeD Capital, Inc.1.44x 3.44x $447K -$2.8M
-
Which has Higher Returns MBAI.CX or QCA.CX?
Quinsam Capital Corp. has a net margin of -179.59% compared to MedBright AI Investments, Inc.'s net margin of -3.32%. MedBright AI Investments, Inc.'s return on equity of 40.84% beat Quinsam Capital Corp.'s return on equity of -41.93%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments, Inc.-- $0.00 $2.6M QCA.CXQuinsam Capital Corp.-- $0.00 $9.2M -
What do Analysts Say About MBAI.CX or QCA.CX?
MedBright AI Investments, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Quinsam Capital Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments, Inc. has higher upside potential than Quinsam Capital Corp., analysts believe MedBright AI Investments, Inc. is more attractive than Quinsam Capital Corp..
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments, Inc.0 0 0 QCA.CXQuinsam Capital Corp.0 0 0 -
Is MBAI.CX or QCA.CX More Risky?
MedBright AI Investments, Inc. has a beta of 1.312, which suggesting that the stock is 31.221% more volatile than S&P 500. In comparison Quinsam Capital Corp. has a beta of 0.680, suggesting its less volatile than the S&P 500 by 32.05%.
-
Which is a Better Dividend Stock MBAI.CX or QCA.CX?
MedBright AI Investments, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quinsam Capital Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments, Inc. pays -- of its earnings as a dividend. Quinsam Capital Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or QCA.CX?
MedBright AI Investments, Inc. quarterly revenues are $114K, which are larger than Quinsam Capital Corp. quarterly revenues of -$4M. MedBright AI Investments, Inc.'s net income of $347.4K is higher than Quinsam Capital Corp.'s net income of $132.1K. Notably, MedBright AI Investments, Inc.'s price-to-earnings ratio is 7.62x while Quinsam Capital Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments, Inc. is 5.78x versus -- for Quinsam Capital Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments, Inc.5.78x 7.62x $114K $347.4K QCA.CXQuinsam Capital Corp.-- -- -$4M $132.1K
-
Which has Higher Returns MBAI.CX or ROBO.CX?
Humanoid Global Holdings Corp. has a net margin of -179.59% compared to MedBright AI Investments, Inc.'s net margin of -15445.34%. MedBright AI Investments, Inc.'s return on equity of 40.84% beat Humanoid Global Holdings Corp.'s return on equity of -548.95%.
Company Gross Margin Earnings Per Share Invested Capital MBAI.CXMedBright AI Investments, Inc.-- $0.00 $2.6M ROBO.CXHumanoid Global Holdings Corp.-- -$0.09 $1.9M -
What do Analysts Say About MBAI.CX or ROBO.CX?
MedBright AI Investments, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Humanoid Global Holdings Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that MedBright AI Investments, Inc. has higher upside potential than Humanoid Global Holdings Corp., analysts believe MedBright AI Investments, Inc. is more attractive than Humanoid Global Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings MBAI.CXMedBright AI Investments, Inc.0 0 0 ROBO.CXHumanoid Global Holdings Corp.0 0 0 -
Is MBAI.CX or ROBO.CX More Risky?
MedBright AI Investments, Inc. has a beta of 1.312, which suggesting that the stock is 31.221% more volatile than S&P 500. In comparison Humanoid Global Holdings Corp. has a beta of 4.043, suggesting its more volatile than the S&P 500 by 304.327%.
-
Which is a Better Dividend Stock MBAI.CX or ROBO.CX?
MedBright AI Investments, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humanoid Global Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. MedBright AI Investments, Inc. pays -- of its earnings as a dividend. Humanoid Global Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MBAI.CX or ROBO.CX?
MedBright AI Investments, Inc. quarterly revenues are $114K, which are larger than Humanoid Global Holdings Corp. quarterly revenues of $16.1K. MedBright AI Investments, Inc.'s net income of $347.4K is higher than Humanoid Global Holdings Corp.'s net income of -$2.5M. Notably, MedBright AI Investments, Inc.'s price-to-earnings ratio is 7.62x while Humanoid Global Holdings Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for MedBright AI Investments, Inc. is 5.78x versus 432.34x for Humanoid Global Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MBAI.CXMedBright AI Investments, Inc.5.78x 7.62x $114K $347.4K ROBO.CXHumanoid Global Holdings Corp.432.34x -- $16.1K -$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
